SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MGV who wrote (1450)1/11/2000 9:27:00 AM
From: Charlie Smith  Read Replies (1) of 1754
 
Hi Mark:

Looks like the LVC market is evolving toward a more corporate-oriented buyer. Fall 99 procedure volume growth, while decent, was not as great as some expected. It could be that the population of potential LVC candidates willing and able to pay $4,800 to $5,000 out of pocket has become depleted over the past 18 months. I'm hearing more and more about corporate plans as the next big buyer block. Pricing and margins will undoubtedly change for procedure providers, a trend made obvious by their stock prices. Now appears to be a volume game. I'd be interested to hear your thoughts on these issues for VISX.

Charlie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext